ACM
ELV icon

Altalis Capital Management’s Elevance Health ELV Stock Holding History

Altalis Capital Management’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-4,176
Closed -$940K – 15
2017
Q4 		$940K Sell
4,176
-4,849
-54% -$1.03M 0.92% 15
2017
Q3 		$1.71M Sell
9,025
-7,607
-46% -$1.45M 1.12% 14
2017
Q2 		$3.13M Sell
16,632
-17,211
-51% -$3.09M 2.38% 12
2017
Q1 		$5.6M Buy
33,843
+2,713
+9% +$432K 5.28% 7
2016
Q4 		$4.48M Buy
31,130
+9,712
+45% +$1.3M 5.02% 8
2016
Q3 		$2.68M Buy
+21,418
New +$2.77M 2.91% 12

Other funds holding ELV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Altalis Capital Management's ELV Position: Q1 2018 in Review

Altalis Capital Management sold out of Elevance Health (ELV) in Q1 2018, closing a stake of 4,176 shares — an estimated $940K sold.

Altalis Capital Management first reported a position in ELV in Q3 2016 and held it in 6 quarters. The position peaked at $5.6M in Q1 2017. 922 funds tracked by Wall St. Rank hold ELV as of Q1 2018.

  • Altalis Capital Management reported no remaining Elevance Health position as of Q1 2018 after selling out during the quarter.
  • Altalis Capital Management sold 4,176 Elevance Health shares in Q1 2018, an estimated $940K.
  • Altalis Capital Management first reported a position in Elevance Health in Q3 2016 and held it in 6 quarters.
  • Altalis Capital Management's Elevance Health position peaked at $5.6M in Q1 2017.
  • 922 funds tracked by Wall St. Rank held Elevance Health as of Q1 2018.

Based on Altalis Capital Management's 13F filing for Q1 2018, filed 15 May 2018.